An experimental diet pill, rimonabant, by Sanofi-Aventis SA, the world’s third biggest drugmaker is showing remarkable promise in clinical trials. Called an “Anti-craving” pill, it’s soon to be tested for its effect on smokers as well.
Researchers indicated 39 percent of test subjects lost more than 10 percent of their body weight during the one-year study [...]
Posts tagged as: